ID/Version |
|
||||||||||||||
Sequence description from provider |
RecName: Full=Midkine {ECO:0000303|PubMed:8827451}; Short=MK {ECO:0000303|PubMed:2345177};AltName: Full=Retanoic acid-responsive protein {ECO:0000303|PubMed:2355021};AltName: Full=Retinoic acid-induced differentiation factor;Flags: Precursor; | ||||||||||||||
Provider | SWISS-PROT | ||||||||||||||
Sequence |
Polypeptide
140
aa
|
||||||||||||||
Source | |||||||||||||||
Annotated genes and markers |
Follow the symbol links to get more information on the GO terms,
expression assays, orthologs, phenotypic alleles, and other information
for the genes or markers below.
|
||||||||||||||
Sequence references in MGI |
J:9111
Kadomatsu K, et al., cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun. 1988 Mar 30;151(3):1312-8
J:10523 Matsubara S, et al., Structure of a retinoic acid-responsive gene, MK, which is transiently activated during the differentiation of embryonal carcinoma cells and the mid-gestation period of mouse embryogenesis. J Biol Chem. 1990 Jun 5;265(16):9441-3 J:34016 Kaneda N, et al., Midkine, a heparin-binding growth/differentiation factor, exhibits nerve cell adhesion and guidance activity for neurite outgrowth in vitro. J Biochem. 1996 Jun;119(6):1150-6 J:35030 Tomomura M, et al., A retinoic acid-responsive gene, MK, found in the teratocarcinoma system. Heterogeneity of the transcript and the nature of the translation product. J Biol Chem. 1990 Jun 25;265(18):10765-70 J:60666 Horiba M, et al., Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J Clin Invest. 2000 Feb;105(4):489-95 J:76278 Nakamura E, et al., Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour. Genes Cells. 1998 Dec;3(12):811-22 J:93637 Kawai H, et al., Lack of the growth factor midkine enhances survival against cisplatin-induced renal damage. Am J Pathol. 2004 Nov;165(5):1603-12 J:102069 Ochiai K, et al., The role of midkine and pleiotrophin in liver regeneration. Liver Int. 2004 Oct;24(5):484-91 J:110520 Zou P, et al., Mice doubly deficient in the midkine and pleiotrophin genes exhibit deficits in the expression of beta-tectorin gene and in auditory response. Lab Invest. 2006 Jul;86(7):645-53 J:117275 Ichihara-Tanaka K, et al., Neuroglycan C is a novel midkine receptor involved in process elongation of oligodendroglial precursor-like cells. J Biol Chem. 2006 Oct 13;281(41):30857-64 J:123392 Muramatsu H, et al., Female infertility in mice deficient in midkine and pleiotrophin, which form a distinct family of growth factors. Genes Cells. 2006 Dec;11(12):1405-17 J:126406 Horiba M, et al., Midkine plays a protective role against cardiac ischemia/reperfusion injury through a reduction of apoptotic reaction. Circulation. 2006 Oct 17;114(16):1713-20 J:146315 Takenaka H, et al., Midkine prevents ventricular remodeling and improves long-term survival after myocardial infarction. Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H462-9 J:147025 Zou P, et al., Midkine, a heparin-binding growth factor, is expressed in neural precursor cells and promotes their growth. J Neurochem. 2006 Dec;99(6):1470-9 J:172537 Liedert A, et al., Midkine-deficiency increases the anabolic response of cortical bone to mechanical loading. Bone. 2011 Apr 1;48(4):945-51 J:181857 Sonobe Y, et al., Midkine inhibits inducible regulatory T cell differentiation by suppressing the development of tolerogenic dendritic cells. J Immunol. 2012 Mar 15;188(6):2602-11 J:209651 Weckbach LT, et al., The cytokine midkine supports neutrophil trafficking during acute inflammation by promoting adhesion via beta2 integrins (CD11/CD18). Blood. 2014 Mar 20;123(12):1887-96 J:225370 Haffner-Luntzer M, et al., Midkine-deficiency delays chondrogenesis during the early phase of fracture healing in mice. PLoS One. 2014;9(12):e116282 J:233132 Neunaber C, et al., Increased trabecular bone formation in mice lacking the growth factor midkine. J Bone Miner Res. 2010 Aug;25(8):1724-35 J:241140 Masuda T, et al., Growth Factor Midkine Promotes T-Cell Activation through Nuclear Factor of Activated T Cells Signaling and Th1 Cell Differentiation in Lupus Nephritis. Am J Pathol. 2017 Apr;187(4):740-751 J:269128 Lautz T, et al., Midkine Controls Arteriogenesis by Regulating the Bioavailability of Vascular Endothelial Growth Factor A and the Expression of Nitric Oxide Synthase 1 and 3. EBioMedicine. 2018 Jan;27:237-246 J:273528 Ueoka C, et al., Neuronal cell adhesion, mediated by the heparin-binding neuroregulatory factor midkine, is specifically inhibited by chondroitin sulfate E. Structural ans functional implications of the over-sulfated chondroitin sulfate. J Biol Chem. 2000 Dec 1;275(48):37407-13 J:273581 Nakanishi T, et al., Expression of syndecan-1 and -3 during embryogenesis of the central nervous system in relation to binding with midkine. J Biochem. 1997 Feb;121(2):197-205 J:273653 Kurosawa N, et al., Glypican-2 binds to midkine: the role of glypican-2 in neuronal cell adhesion and neurite outgrowth. Glycoconj J. 2001 Jun;18(6):499-507 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|